Delivery Order SPE2DB20D1004-SPE2DB22FE9D3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,861.23 Firm Fixed Price Delivery Order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a cardiovascular medication. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,383.95 firm fixed-price delivery order is for the supply of PRADAXA 150 MG CAPSULE, a cardiovascular medication. The award has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,474.32 Firm Fixed Price Delivery Order is for the supply of PRADAXA 75 MG CAPSULE UU 60S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,045.72 fixed-price delivery order is for the procurement of Pradaxa 150 mg capsules. The contract has an ultimate completion date of October 16, 2023 and was awarded on October 13, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,787.19, is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a specialty pharmaceutical product. The award was made on a firm fixed-price basis without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,387.67, is a Firm Fixed Price Delivery Order for the supply of PRADAXA 150 MG CAPSULE UU 60S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pradaxa 150 mg capsules. The award, valued at $3,310.70, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to supply a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,627.42, is a Firm Fixed Price Delivery Order for the supply of PRADAXA 150 MG CAPSULE UU 60S. The contract has an ultimate completion date of January 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,530.86 firm fixed-price delivery order is for the pharmaceutical drug Pradaxa 150 mg capsules. The contract has an ultimate completion date of September 24, 2021 and was awarded on September 23, 2021. There is no set-aside designation for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,115.91, for the provision of Pradaxa 150 mg capsules. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FE9D3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,185.92 firm fixed-price delivery order is for PRADAXA 150 MG CAPSULE UU 60S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical healthcare commodities to support military and veterans' healthcare programs globally. The contract award did not utilize any set-aside designations, indicating full and open competition. AmerisourceBergen has also secured a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/24/21 |